ResearcherUCL School of PharmacyNo recent work listed

Mandana Emamzadeh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5002236492. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper · 2019: 1 paper

Papers 2

Dual Controlled Delivery of Gemcitabine and Cisplatin Using Polymer-Modified Thermosensitive Liposomes for Pancreatic Cancer. Co-author DOI 10.1021/acsabm.9b00007 ↗
Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancreatic cancer. Co-author DOI 10.1039/c7tb02899g ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

George Pasparakis · 2 shared papers, 2018–2019 · strength 0.28
- Paper Dual Controlled Delivery of Gemcitabine and Cisplatin Using Polymer-Modified Thermosensitive Liposomes for Pancreatic C… DOI 10.1021/acsabm.9b00007 ↗
- Paper Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancre… DOI 10.1039/c7tb02899g ↗
Mina Emamzadeh · 1 shared paper, 2019 · strength 0.16
- Paper Dual Controlled Delivery of Gemcitabine and Cisplatin Using Polymer-Modified Thermosensitive Liposomes for Pancreatic C… DOI 10.1021/acsabm.9b00007 ↗
Patrick Couvreur · 1 shared paper, 2018 · strength 0.12
- Paper Dual controlled delivery of squalenoyl-gemcitabine and paclitaxel using thermo-responsive polymeric micelles for pancre… DOI 10.1039/c7tb02899g ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.